CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
CVI Accepts, published online ahead of print on 19 March 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00018-08v1
15/5/750    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Irwin, S. M.
Right arrow Articles by Izzo, A. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Irwin, S. M.
Right arrow Articles by Izzo, A. A.

 Previous Article  |  Next Article 

Clin. Vaccine Immunol. doi:10.1128/CVI.00018-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Analysis of the immune response in the C57BL/6 mouse model induced by three Mycobacterium bovis BCG sub-strains with diverse regions of deletion

S. M. Irwin, A. Goodyear, A. Keyser, R. Christensen, J. M. Troudt, J. L. Taylor, A. Bohsali, V. Briken, and A. A. Izzo*

Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80524, and Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742

* To whom correspondence should be addressed. Email: Angelo.Izzo{at}colostate.edu.


   Abstract

This study was performed to examine the adaptive immune response generated by three Mycobacterium bovis, BCG sub-strains to determine if the number of genomic regions of deletion played a significant role in determining the magnitude of the immune response or affected their ability to reduce the bacterial burden following low dose aerosol challenge with virulent M. tuberculosis. BCG Connaught, Pasteur and Sweden were chosen as representative sub-strains as they possessed many, intermediate and few regions of deletion respectively, when compared to changes in the genome in various regions. Mice were vaccinated subcutaneously and then examined at 14, 21 and 42 days post-vaccination. BCG was observed in the spleen, lung and lymph nodes. BCG Connaught induced a greater pulmonary T cell response than the other two sub-strains at day 14 post-vaccination, although by 42 days post-vaccination activated T cell levels dropped to levels observed in control mice for all three sub-strains. Amongst the three sub-strains, BCG Connaught induced significantly greater levels of IL-12 in bone marrow derived macrophage cultures. Mice challenged at days 14, 21 and 42 post-vaccination displayed an equal capacity to reduce the bacterial burden in the lungs and spleen. The data provide evidence that although BCG sub-strains generate qualitatively and quantitatively different immune responses, they induce a similar reduction in bacterial burden against challenge with virulent M. tuberculosis in the mouse model of tuberculosis. The data raise questions about assessing vaccine immune responses and the relationship to a vaccines ability to reduce the bacterial burden.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.